Pro-Business Foundation Backs J&J's Stelara Antitrust Win
By Matthew Santoni · August 19, 2026, 8:25 PM EDT
Insurer CareFirst's bid to revive an antitrust lawsuit against Johnson & Johnson over its acquisition of patents affecting competitors would throw cold water over drug company mergers, burden government regulators and...
To view the full article, register now.